Neonatal transient tachypnea. Transient tachypnoea of newborn
Conditions
Interventions
Intervention 1: Intervention group: 0.1 ml/kg salbutamol and 2 ml normal saline 0.9% plus 5 to 6 l/min oxygen for 20 min will be nebulized. Intervention 2: Control group: 2 ml normal saline 0.9% plus
Treatment - Drugs
Placebo
Intervention group: 0.1 ml/kg salbutamol and 2 ml normal saline 0.9% plus 5 to 6 l/min oxygen for 20 min will be nebulized.
Control group: 2 ml normal saline 0.9% plus 5 to 6 l/min oxygen for 20 min will be nebulized.
Sponsors
Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Months to 11 Months
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age of 34 to 47 weeks; neonatal transient tachypnea. Exclusion criteria: Pneumothorax; maternal addiction; respiratory distress syndrome; meconium aspiration; pneumonia; sepsis; congenital heart disease; pulmonary hypertension.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of breathing. Timepoint: Before and 0.5, 1 and 4 hours after treatment. Method of measurement: By physical examination.;TTN clinical score. Timepoint: Before and 0.5, 1 and 4 hours after treatment. Method of measurement: By physical examination.;Arterial oxygen saturation. Timepoint: Before and 4 hours after treatment. Method of measurement: By checking arterial blood sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Nishtman Sadeghi
Fatemieh Hospital
Outcome results
None listed